Deals & IPOs

Anthropic Shares Slump to $88.61 as IPO Buyers Retreat

Anthropic's ANT has slid from a $111.50 IPO open to about $88.61. Traders watch $86.50 support and $93.12 resistance as Bitget's allocation doubles Gate's.

By Olivia Hart

2 min read

ANT: Can Buyers Turn This Rebound Into a Recovery?
ANT: Can Buyers Turn This Rebound Into a Recovery?nattanan23 / pixabay

What's News

  • ANT opened at $111.50 and closed its first session at $97.17; it now trades near $88.61.
  • Immediate support sits at $86.50–$87.70; first resistance at $93.12; major resistance at $102.43.
  • Bitget secured 153,774 IPO shares with a 10.06% VIP allocation rate versus Gate's 92,100 shares at 5.03%.
  • Analyst Yusuftsauri requires a hold of support and a reclaim of $93.12 before calling a recovery.

By Olivia Hart

Anthropic, PBC Class A shares (BATS: ANT) have fallen roughly 21% from their $111.50 IPO opening price, changing hands near $88.61 after closing the first trading session at $97.17. The selling pressure, documented by TradingView analyst Yusuftsauri, has wiped out the early euphoria and left traders watching a narrow band of support around $86.50–$87.70.

The numbers frame the story. A buyer who purchased at the open is now sitting on a loss of about $22.89 per share — near 21% — in a matter of sessions. That is the kind of drawdown that turns IPO excitement into a test of conviction.

Where are the key technical levels?

Yusuftsauri's 15-minute chart analysis identifies three levels that will decide whether this is a bottom or a pause.

  • Immediate support: $86.50–$87.70. This is where buyers recently attempted to defend the price. Holding the zone, the analyst writes, "could give the current rebound some room to develop."
  • First resistance: $93.12. Described as "the first important level bulls need to reclaim," a convincing breakout and hold above it would improve the short-term structure.
  • Major resistance: $102.43. If momentum returns, this is the next significant upside target — though it still sits below the opening print.

Even a full recovery to $102.43 would leave ANT nearly 8% under its first-trade price. The market, not the allocation story, sets the ceiling.

What does the analyst actually recommend?

Caution, explicitly. "I'm not rushing into a long position just because price is bouncing. I want to see buyers defend support and reclaim $93.12 before becoming more confident about a recovery," Yusuftsauri writes.

The analyst also flags the downside scenario: a breakdown below the recent support area could expose ANT to another leg lower. In plain terms, a bounce is not yet a trend, and buying it unconfirmed carries defined risk.

How were the IPO shares distributed?

The allocation data adds a wrinkle. Bitget secured 153,774 Anthropic shares in the IPO distribution, against Gate's reported 92,100 — a gap of more than 61,600 shares. Bitget's VIP allocation rate came in at 10.06%, exactly double Gate's 5.03%.

Yusuftsauri draws the right conclusion from the discrepancy: "allocation strength doesn't automatically translate into bullish price action." Access to shares is not the same as demand for them, and the chart since the open makes that point bluntly.

What happens next?

For traders exploring the opportunity through Bitget, the analyst frames the open question as how ANT behaves now that the initial IPO excitement has faded. The stated approach is disciplined: "Structure first, confirmation second. No FOMO."

The takeaway is simple. ANT needs to hold $86.50–$87.70 and then reclaim $93.12 before anyone can credibly call this a recovery; until both happen, the rebound is just a bounce with unfinished proof.

Source: tradingview.com

Share this article:

More from Olivia Hart

Olivia Hart

Show full bio

Staff writer covering people, launches and day-to-day practice in entrepreneurship, startups and venture funding at Business Bearings.

2,535 articles

Related articles

« Previous article